Further analysis suggests that the CSF p-tau level was negatively correlated with MMSE, MoCA, and the specific scores of ECAS in patients with ALS and cognitive impairment, particularly in the area of executive function. The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.